Influence of the vitreomacular interface on outcomes of ranibizumab therapy in neovascular age-related macular degeneration. [electronic resource]
Producer: 20140129Description: 2620-2629 p. digitalISSN:- 1549-4713
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Double-Blind Method
- Female
- Humans
- Intravitreal Injections
- Male
- Prospective Studies
- Ranibizumab
- Retinal Diseases -- pathology
- Retreatment
- Tissue Adhesions
- Tomography, Optical Coherence
- Treatment Outcome
- Visual Acuity -- physiology
- Vitreous Body -- pathology
- Wet Macular Degeneration -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.